| Product Code: ETC13149197 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Neuromodulation Devices Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Neuromodulation Devices Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Neuromodulation Devices Market Revenues & Volume, 2021 & 2031F |
3.3 North America Neuromodulation Devices Market - Industry Life Cycle |
3.4 North America Neuromodulation Devices Market - Porter's Five Forces |
3.5 North America Neuromodulation Devices Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Neuromodulation Devices Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 North America Neuromodulation Devices Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 North America Neuromodulation Devices Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 North America Neuromodulation Devices Market Revenues & Volume Share, By Biomaterial, 2021 & 2031F |
3.10 North America Neuromodulation Devices Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 North America Neuromodulation Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Neuromodulation Devices Market Trends |
6 North America Neuromodulation Devices Market, 2021 - 2031 |
6.1 North America Neuromodulation Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Neuromodulation Devices Market, Revenues & Volume, By Spinal Cord Stimulators, 2021 - 2031 |
6.1.3 North America Neuromodulation Devices Market, Revenues & Volume, By Deep Brain Stimulators, 2021 - 2031 |
6.1.4 North America Neuromodulation Devices Market, Revenues & Volume, By Sacral Nerve Stimulators, 2021 - 2031 |
6.1.5 North America Neuromodulation Devices Market, Revenues & Volume, By Vagus Nerve Stimulators, 2021 - 2031 |
6.1.6 North America Neuromodulation Devices Market, Revenues & Volume, By Transcranial Magnetic Stimulators, 2021 - 2031 |
6.1.7 North America Neuromodulation Devices Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 North America Neuromodulation Devices Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Neuromodulation Devices Market, Revenues & Volume, By Internal, 2021 - 2031 |
6.2.3 North America Neuromodulation Devices Market, Revenues & Volume, By External, 2021 - 2031 |
6.3 North America Neuromodulation Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Neuromodulation Devices Market, Revenues & Volume, By Parkinson's Disease, 2021 - 2031 |
6.3.3 North America Neuromodulation Devices Market, Revenues & Volume, By Chronic Pain, 2021 - 2031 |
6.3.4 North America Neuromodulation Devices Market, Revenues & Volume, By Migraine, 2021 - 2031 |
6.3.5 North America Neuromodulation Devices Market, Revenues & Volume, By Epilepsy, 2021 - 2031 |
6.3.6 North America Neuromodulation Devices Market, Revenues & Volume, By Tremor, 2021 - 2031 |
6.3.7 North America Neuromodulation Devices Market, Revenues & Volume, By Depression, 2021 - 2031 |
6.3.8 North America Neuromodulation Devices Market, Revenues & Volume, By Urinary & Faecal Incontinence, 2021 - 2031 |
6.3.9 North America Neuromodulation Devices Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 North America Neuromodulation Devices Market, Revenues & Volume, By Biomaterial, 2021 - 2031 |
6.4.2 North America Neuromodulation Devices Market, Revenues & Volume, By Polymeric Biomaterial, 2021 - 2031 |
6.4.3 North America Neuromodulation Devices Market, Revenues & Volume, By Metallic Biomaterial, 2021 - 2031 |
6.4.4 North America Neuromodulation Devices Market, Revenues & Volume, By Ceramic Biomaterial, 2021 - 2031 |
6.5 North America Neuromodulation Devices Market, Revenues & Volume, By End-use, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Neuromodulation Devices Market, Revenues & Volume, By Hospitals & Ambulatory Surgery Centers (ASC), 2021 - 2031 |
6.5.3 North America Neuromodulation Devices Market, Revenues & Volume, By Clinics & Physiotherapy Centers, 2021 - 2031 |
6.5.4 North America Neuromodulation Devices Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Neuromodulation Devices Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Neuromodulation Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.1 United States (US) Neuromodulation Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.2 Canada Neuromodulation Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.3 Rest of North America Neuromodulation Devices Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3 North America Neuromodulation Devices Market Revenues & Volume Share, By Technology, 2021 & 2031F |
7.3.1 United States (US) Neuromodulation Devices Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.2 Canada Neuromodulation Devices Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3.3 Rest of North America Neuromodulation Devices Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4 North America Neuromodulation Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.1 United States (US) Neuromodulation Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.2 Canada Neuromodulation Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.3 Rest of North America Neuromodulation Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Neuromodulation Devices Market, Revenues & Volume, By Biomaterial, 2021 - 2031 |
7.5.1 United States (US) Neuromodulation Devices Market, Revenues & Volume, By Biomaterial, 2021 - 2031 |
7.5.2 Canada Neuromodulation Devices Market, Revenues & Volume, By Biomaterial, 2021 - 2031 |
7.5.3 Rest of North America Neuromodulation Devices Market, Revenues & Volume, By Biomaterial, 2021 - 2031 |
7.6 North America Neuromodulation Devices Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.6.1 United States (US) Neuromodulation Devices Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.6.2 Canada Neuromodulation Devices Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.6.3 Rest of North America Neuromodulation Devices Market, Revenues & Volume, By End-use, 2021 - 2031 |
8 North America Neuromodulation Devices Market Key Performance Indicators |
9 North America Neuromodulation Devices Market - Export/Import By Countries Assessment |
10 North America Neuromodulation Devices Market - Opportunity Assessment |
10.1 North America Neuromodulation Devices Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Neuromodulation Devices Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10.3 North America Neuromodulation Devices Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.4 North America Neuromodulation Devices Market Opportunity Assessment, By Application, 2021 & 2031F |
10.5 North America Neuromodulation Devices Market Opportunity Assessment, By Biomaterial, 2021 & 2031F |
10.6 North America Neuromodulation Devices Market Opportunity Assessment, By End-use, 2021 & 2031F |
11 North America Neuromodulation Devices Market - Competitive Landscape |
11.1 North America Neuromodulation Devices Market Revenue Share, By Companies, 2022 |
11.2 North America Neuromodulation Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here